Bank of Montreal
RAPT

Bank of Montreal’s RAPT Therapeutics RAPT Stock Holding History

Bank of Montreal’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,877
Closed -$18.3K – 3688
2025
Q1 		$18.3K Buy
+1,877
New +$18.5K ﹤0.01% 3232
2021
Q2 		– Sell
-37
Closed -$7K – 4671
2021
Q1 		$7K Sell
37
-174
-82% -$28.7K ﹤0.01% 4535
2020
Q4 		$36K Buy
211
+148
+235% +$32.2K ﹤0.01% 4118
2020
Q3 		$17K Sell
63
-44
-41% -$9.77K ﹤0.01% 3906
2020
Q2 		$23K Buy
107
+106
+10,600% +$16.4K ﹤0.01% 3792
2020
Q1 		$0 Sell
1
-24
-96% -$5.47K ﹤0.01% 4594
2019
Q4 		$5K Buy
+25
New +$4.6K ﹤0.01% 4700

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Bank of Montreal's RAPT Position: Q2 2025 in Review

Bank of Montreal sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 1,877 shares — an estimated $18.3K sold.

Bank of Montreal first reported a position in RAPT in Q4 2019 and held it in 7 quarters. The position peaked at $36K in Q4 2020. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Bank of Montreal reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Bank of Montreal sold 1,877 RAPT Therapeutics shares in Q2 2025, an estimated $18.3K.
  • Bank of Montreal first reported a position in RAPT Therapeutics in Q4 2019 and held it in 7 quarters.
  • Bank of Montreal's RAPT Therapeutics position peaked at $36K in Q4 2020.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Bank of Montreal's 13F filing for Q2 2025, filed 5 Aug 2025.